Scrip
Keeping the faith with anticancers
12 March 2010
Peter Charlish
It has been a bad week for anticancer drug development, with two late-stage projects coming to grief and a third being shelved.
First came news that Danish company Genmab’s head and neck cancer product, zalutumumab (HuMax-EGFr), had failed to meet the primary endpoint in its first pivotal Phase...
Please Login to read the full article.
12 March 2010
Peter Charlish
First came news that Danish company Genmab’s head and neck cancer product, zalutumumab (HuMax-EGFr), had failed to meet the primary endpoint in its first pivotal Phase...
Please Login to read the full article.
RELATED CONTENT
EVENTS
01 January 1970
London, UK
01 January 1970
San Diego, US
01 January 1970
Providence, Rhode Island, and San Francisco, California
JOB OF THE WEEK
Promote your vacancy here
